THEMISMED — Themis Medicare Share Price
0.000.00%
Last trade - 00:00- IN₹19.24bn
- IN₹19.91bn
- IN₹3.54bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.28 | ||
| Price to Tang. Book | 5.29 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 5.28 | ||
| EV to EBITDA | 37.78 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 10.2% | ||
| Return on Equity | 13.28% | ||
| Operating Margin | 11.18% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 1,837.55 | 2,015.88 | 2,306.7 | 3,946.14 | 3,543.23 | n/a | n/a | 10.85% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +44.02 | +103.55 | -21.93 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Themis Medicare Limited is an India-based company, which is engaged in the manufacturing of pharmaceutical products, especially in formulation and active pharmaceutical ingredients (API) activity. The Company operates through one segment: Pharmaceuticals. The Company manufactures therapeutic pharma products, differential healthcare products, and APIs based in India. Its analgesic and anti-inflammatory products include Aquadol Tpm Gel, Etojet 90 10'S, Etojet 120 10'S, Etojet Mr Tablets 10'S, Etojet XP Gel, Themidol-P Tab 10's, Dhoom, Aquadol inj, Dyloaqua inj, Joydol -P, Joydol -SP, Joydol -TH, and Nimujet Gel. Its Analgesics products include Anemol, Tazowin, Themidol, Themidol. Its Anesthesia products include Bupicaine 0.25%, Ketmin 2 Vial, Ketmin 5, Ropicaine 2, Themicaine 2%, and more. Its subsidiaries include Artemis Biotech Limited, Themis Lifestyle Private Limited, and Carpo Medical Limited (UK).
Directors
- Hoshang Sinor NEC (76)
- Sachin Patel CEO (46)
- Dinesh Patel VCH (73)
- Tushar Dalal CFO
- Sangameshwar Lyer CCO
- Jayshree Patel EDR (66)
- Luis Dias OTH
- Shashikant Kurani OTH
- T. Damodar Reddy OTH
- Gabar Gulacsi DRC
- Hariharan Subramaniam DRC
- Rajneesh Anand NED (60)
- Lajos Kovacs NED (52)
- Bhasker Iyer IND (65)
- Manjul Sandhu IND
- Vijay Agarwal NID (62)
- Last Annual
- March 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- May 31st, 1969
- Public Since
- April 2nd, 2007
- No. of Shareholders
- 6,054
- No. of Employees
- 996
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 92,040,120
- Address
- 11/12 Udyog Nagar, MUMBAI, 400104
- Web
- https://www.themismedicare.com/
- Phone
- +91 2267607080
- Contact
- Sangameshwar Iyer
- Auditors
- Krishaan & Co.
Upcoming Events for THEMISMED
Q1 2025 Themis Medicare Ltd Earnings Release
Themis Medicare Ltd Annual Shareholders Meeting
Similar to THEMISMED
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the Themis Medicare share price?
As of Today at 19:21 UTC, shares in Themis Medicare are trading at IN₹209.00. This share price information is delayed by 15 minutes.
How has the Themis Medicare share price performed this year?
Shares in Themis Medicare last closed at IN₹209.00 and the price had moved by +45.09% over the past 365 days. In terms of relative price strength the Themis Medicare share price has outperformed the S&P BSE 100 Index by +12.54% over the past year.
What are the analyst and broker recommendations for Themis Medicare?
There is no consensus recommendation for this security.
What is the Themis Medicare dividend yield?
The Themis Medicare dividend yield is 0.24% based on the trailing twelve month period.
Does Themis Medicare pay a dividend?
Last year, Themis Medicare paid a total dividend of IN₹0.50, and it currently has a trailing dividend yield of 0.24%. We do not have any data on when Themis Medicare is to next pay dividends.
When does Themis Medicare next pay dividends?
We do not have data on when Themis Medicare is to next pay dividends. The historic dividend yield on Themis Medicare shares is currently 0.24%.
How do I buy Themis Medicare shares?
To buy shares in Themis Medicare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Themis Medicare?
As of the previous close price of IN₹209.00, shares in Themis Medicare had a market capitalisation of IN₹19.24bn.
Where are Themis Medicare shares listed?
Here are the trading details for Themis Medicare:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: THEMISMED
What kind of share is Themis Medicare?
Based on an overall assessment of its quality, value and momentum Themis Medicare is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Themis Medicare share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Themis Medicare share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Themis Medicare. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +10.25%.
As of the last closing price of IN₹209.00, shares in Themis Medicare were trading +11.49% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Themis Medicare PE Ratio?
The Themis Medicare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹209.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Themis Medicare?
Themis Medicare's management team is headed by:
- Hoshang Sinor - NEC
- Sachin Patel - CEO
- Dinesh Patel - VCH
- Tushar Dalal - CFO
- Sangameshwar Lyer - CCO
- Jayshree Patel - EDR
- Luis Dias - OTH
- Shashikant Kurani - OTH
- T. Damodar Reddy - OTH
- Gabar Gulacsi - DRC
- Hariharan Subramaniam - DRC
- Rajneesh Anand - NED
- Lajos Kovacs - NED
- Bhasker Iyer - IND
- Manjul Sandhu - IND
- Vijay Agarwal - NID